Potkin, S.G., Saha, A.R., Kujawa, M.J., Carson, W.H., Ali, M., Stock, E., Stringfellow, J., Ingenito, G. and Marder, S.R. (2003) Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs. placebo in patients with schizophrenia and schizoaffective disorder. Archives of General Psychiatry, 60, 681-690. doi:10.1001/archpsyc.60.7.681

has been cited by the following article:

• TITLE: Withdrawal seizure associated with high dosage of aripiprazole and fluoxetine: a case report

  AUTHORS: Jian-An Su, Shih-Yong Chou, Ching-Shu Tsai, Tai-Hsin Hung

  KEYWORDS: Aripiprazole; High Dosage; Withdrawal Seizure

  JOURNAL NAME: Open Journal of Psychiatry, Vol.1 No.2, July 12, 2011

  ABSTRACT: Aripiprazole, a third-generation antipsychotic, has been considered to have a high safety profile and rare withdrawal symptoms. We reported the case of a schizophrenic patient with a significant obsession, who was treated with a high dosage of aripiprazole and fluoxetine. Generalized tonic-clonic seizure occurred two days after abruptly stopping these two medications. Gradually tapering aripiprazole is suggested in clinical practice, especially when using a high dosage.